Pharma Journalist -

Merck, a leading science and technology company, today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization…
Read More...

ImaginAb Inc. announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. to supply 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer…
Read More...

Almirall, S.A. a global biopharmaceutical company based in Barcelona, and Tyris Therapeutics, a next-generation gene therapy company founded by Columbus Venture Partners, have announced…
Read More...

AM-Pharma B.V., an emerging leader focused on the treatment of kidney disease, sepsis and organ injury, announced that the first patients with COVID-19 infection and sepsis-associated…
Read More...

SMi Reports: Innovations in technologies and applications of RNA-based medicine We have witnessed significant growth and innovation in the RNA market. The 2-day agenda for the…
Read More...

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas MD…
Read More...

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR). The ground-breaking project,…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its…
Read More...

Dewpoint Therapeutics, the biomolecular condensates company, announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of…
Read More...

Morphic Therapeutic a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced the expansion of its…
Read More...